Oppenheimer Has Lowered Expectations for Amrize (NYSE:AMRZ) Stock Price

Amrize (NYSE:AMRZ) had its price target dropped by Oppenheimer from $55.00 to $52.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer‘s price target points to a potential upside of 20.15% from the stock’s previous close.

Several other analysts have also weighed in on AMRZ. Citigroup decreased their price target on Amrize from $58.00 to $50.00 and set a “buy” rating on the stock in a report on Friday, October 2nd. Deutsche Bank Aktiengesellschaft lowered their price target on Amrize from $64.00 to $56.00 and set a “buy” rating for the company in a research report on Wednesday, September 23rd. Stephens cut their price objective on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 12th. JPMorgan Chase & Co. lowered their target price on shares of Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a report on Tuesday, October 13th. Finally, Royal Bank Of Canada cut their price target on shares of Amrize from $48.00 to $32.00 and set an “underperform” rating on the stock in a report on Friday, October 9th. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $49.06.

Amrize Trading Up 4.6%

AMRZ traded up $1.90 on Monday, hitting $43.28. The company had a trading volume of 1,449,939 shares, compared to its average volume of 3,434,809. The business’s fifty day simple moving average is $39.73 and its 200 day simple moving average is $50.59. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. Amrize has a 12-month low of $35.78 and a 12-month high of $65.94. The company has a market cap of $23.94 billion, a PE ratio of 19.56, a PEG ratio of 1.55 and a beta of 0.20.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $0.98 earnings per share. Equities research analysts expect that Amrize will post 2.41 EPS for the current year.

Insider Activity

In related news, CEO Jan Jenisch purchased 4,000 shares of Amrize stock in a transaction that occurred on Wednesday, September 2nd. The shares were bought at an average price of $42.50 per share, with a total value of $170,000.00. Following the purchase, the chief executive officer directly owned 519,000 shares of the company’s stock, valued at approximately $22,057,500. This represents a 0.78% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jaime Hill acquired 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average price of $47.12 per share, with a total value of $70,680.00. Following the acquisition, the insider directly owned 29,698 shares in the company, valued at $1,399,369.76. This represents a 5.32% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders bought 48,983 shares of company stock valued at $2,158,755. Insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

A number of institutional investors have recently modified their holdings of the stock. Rakuten Investment Management Inc. purchased a new stake in shares of Amrize in the third quarter valued at approximately $1,220,000. Bank Julius Baer & Co. Ltd Zurich raised its position in Amrize by 8.8% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company’s stock valued at $78,985,000 after purchasing an additional 170,551 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Amrize in the 3rd quarter worth $49,000. MGO One Seven LLC lifted its holdings in shares of Amrize by 21.3% in the 3rd quarter. MGO One Seven LLC now owns 24,104 shares of the company’s stock worth $901,000 after buying an additional 4,228 shares during the period. Finally, CHICAGO TRUST Co NA grew its position in shares of Amrize by 90.8% during the 3rd quarter. CHICAGO TRUST Co NA now owns 25,638 shares of the company’s stock worth $959,000 after buying an additional 12,202 shares in the last quarter.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.